This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comThe incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Although survival has improved, cure rates remain poor, with <20% of patients surviving 5 years. This is the first study to explore methylome, transcriptome and ENCODE data to characterize the role of methylation in EAC. We investigate the genome-wide methylation profile of 250 samples includ...
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
NIH grant U01CA182940 (EGL, WDH, WMG, SKM, KC); NIH grants P50CA150964, U54CA163060 and P30CA43703 (...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
Krause L, Nones K, Loffler KA, et al. Identification of the CIMP-like subtype and aberrant methylati...
BACKGROUND & AIMS: Esophageal adenocarcinomas (EACs) are heterogeneous and often preceded by Bar...
BACKGROUND & AIMS: Esophageal adenocarcinomas (EACs) are heterogeneous and often preceded by Barrett...
Background: Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithe...
Background Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithel...
IntroductionEsophageal squamous cell carcinoma (ESCC) is a cancer of variable outcomes with limited ...
Esophageal adenocarcinoma has one of the poorest outcomes of all solid tumors, attributable, at leas...
IntroductionEsophageal squamous cell carcinoma (ESCC) is a cancer of variable outcomes with limited ...
Abstract Background Aberrant DNA methylations are significantly associated with esophageal squamous ...
Epigenetic landscapes can shape physiologic and disease phenotypes. We used integrative, high resolu...
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
NIH grant U01CA182940 (EGL, WDH, WMG, SKM, KC); NIH grants P50CA150964, U54CA163060 and P30CA43703 (...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
Krause L, Nones K, Loffler KA, et al. Identification of the CIMP-like subtype and aberrant methylati...
BACKGROUND & AIMS: Esophageal adenocarcinomas (EACs) are heterogeneous and often preceded by Bar...
BACKGROUND & AIMS: Esophageal adenocarcinomas (EACs) are heterogeneous and often preceded by Barrett...
Background: Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithe...
Background Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithel...
IntroductionEsophageal squamous cell carcinoma (ESCC) is a cancer of variable outcomes with limited ...
Esophageal adenocarcinoma has one of the poorest outcomes of all solid tumors, attributable, at leas...
IntroductionEsophageal squamous cell carcinoma (ESCC) is a cancer of variable outcomes with limited ...
Abstract Background Aberrant DNA methylations are significantly associated with esophageal squamous ...
Epigenetic landscapes can shape physiologic and disease phenotypes. We used integrative, high resolu...
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,...
The incidence of esophageal adenocarcinoma (EAC) has risen significantly over recent decades. Althou...
NIH grant U01CA182940 (EGL, WDH, WMG, SKM, KC); NIH grants P50CA150964, U54CA163060 and P30CA43703 (...